The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Multimodality Molecular Imaging of Tumor Angiogenesis
Abstract
Molecular imaging is a key component of 21st-century cancer management. The vascular endothelial growth factor (VEGF)/VEGF receptor signaling pathway and integrin alpha v beta 3, a cell adhesion molecule, play pivotal roles in regulating tumor angiogenesis, the growth of new blood vessels. This review summarizes the current status of tumor angiogenesis imaging with SPECT, PET, molecular MRI, targeted ultrasound, and optical techniques. For integrin alpha v beta 3 imaging, only nanoparticle-based probes, which truly target the tumor vasculature rather than tumor cells because of poor extravasation, are discussed. Once improvements in the in vivo stability, tumor-targeting efficacy, and pharmacokinetics of tumor angiogenesis imaging probes are made, translation to clinical applications will be critical for the maximum benefit of these novel agents. The future of tumor angiogenesis imaging lies in multimodality and nanoparticle-based approaches, imaging of protein-protein interactions, and quantitative molecular imaging. Combinations of multiple modalities can yield complementary information and offer synergistic advantages over any modality alone. Nanoparticles, possessing multifunctionality and enormous flexibility, can allow for the integration of therapeutic components, targeting ligands, and multimodality imaging labels into one entity, termed "nanomedicine," for which the ideal target is tumor neovasculature. Quantitative imaging of tumor angiogenesis and protein-protein interactions that modulate angiogenesis will lead to more robust and effective monitoring of personalized molecular cancer therapy. Multidisciplinary approaches and cooperative efforts from many individuals, institutions, industries, and organizations are needed to quickly translate multimodality tumor angiogenesis imaging into multiple facets of cancer management. Not limited to cancer, these novel agents can also have broad applications for many other angiogenesis-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Probing the Cytotoxicity of Semiconductor Quantum Dots
Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2004) · Nano Letters · doi:10.1021/nl0347334 · Cited by 3,391
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
In vivo near-infrared fluorescence imaging
Frangioni, J. V. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.08.007 · Cited by 2,653
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087
Jares-Erijman, E. A., & Jovin, T. M. (2003) · Nature Biotechnology · doi:10.1038/nbt896 · Cited by 1,824
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Chemically Functionalized Carbon Nanotubes
Balasubramanian, K., & Burghard, M. (2005) · Small · doi:10.1002/smll.200400118 · Cited by 1,769
A combined PET/CT scanner for clinical oncology.
Beyer, T., Townsend, D. W., Brun, T., Kinahan, P. E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L. G., & Nutt, R. (2000) · PubMed · Cited by 1,659
Cytotoxicity of Colloidal CdSe and CdSe/ZnS Nanoparticles
Kirchner, C., Liedl, T., Kudera, S., Pellegrino, T., Muñoz Javier, A., Gaub, H. E., Stölzle, S., Fertig, N., & Parak, W. J. (2005) · Nano Letters · doi:10.1021/nl047996m · Cited by 1,619
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,613
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,436
Self-citationWeissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2020) · Nano-Enabled Medical Applications · doi:10.1201/9780429399039-14 · Cited by 1,213
Self-citationArming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Singh, R., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., & Kostarelos, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509009103 · Cited by 1,043
Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects
Cai, W., Shin, D.-W., Chen, K., Gheysens, O., Cao, Q., Wang, S. X., Gambhir, S. S., & Chen, X. (2006) · Nano Letters · doi:10.1021/nl052405t · Cited by 948
Self-citationPharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 845
Carbon nanotubes as nanomedicines: From toxicology to pharmacology☆
LACERDA, L., BIANCO, A., PRATO, M., & KOSTARELOS, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.015 · Cited by 839
Molecular imaging in drug discovery and development
Rudin, M., & Weissleder, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1007 · Cited by 815
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
MicroPET: a high resolution PET scanner for imaging small animals
Cherry, S. R., Shao, Y., Silverman, R. W., Meadors, K., Siegel, S., Chatziioannou, A., Young, J. W., Jones, W., Moyers, J. C., Newport, D., et al. (1997) · IEEE Transactions on Nuclear Science · doi:10.1109/23.596981 · Cited by 609
Pradhan, N. C., & Peng, X. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068360v · Cited by 600
Metabolic Imaging by Hyperpolarized 13C Magnetic Resonance Imaging for In vivo Tumor Diagnosis
Golman, K., Zandt, R. I., Lerche, M., Pehrson, R., & Ardenkjaer-Larsen, J. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2564 · Cited by 591
Nanoplatforms for Targeted Molecular Imaging in Living Subjects
Cai, W., & Chen, X. (2007) · Small · doi:10.1002/smll.200700351 · Cited by 563
Self-citationHaubner, R., Wester, H. J., Weber, W., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch–Schmidtke, R., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 563
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Selvan, S. T., Patra, P. K., Ang, C. Y., & Ying, J. Y. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604245 · Cited by 506
Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5638 · Cited by 497
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., & Jayson, G. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603515 · Cited by 484
Quantum Dots with a Paramagnetic Coating as a Bimodal Molecular Imaging Probe
Mulder, W. J. M., Koole, R., Brandwijk, R. J., Storm, G., Chin, P. T. K., Strijkers, G. J., de Mello Donegá, C., Nicolay, K., & Griffioen, A. W. (2006) · Nano Letters · doi:10.1021/nl051935m · Cited by 482
Pradhan, N., Battaglia, D. M., Liu, Y., & Peng, X. (2007) · Nano Letters · doi:10.1021/nl062336y · Cited by 459
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
McDevitt, M. R., Chattopadhyay, D., Kappel, B. J., Jaggi, J. S., Schiffman, S. R., Antczak, C., Njardarson, J. T., Brentjens, R., & Scheinberg, D. A. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.039131 · Cited by 452
Echocardiographic Destruction of Albumin Microbubbles Directs Gene Delivery to the Myocardium
Shohet, R. V., Chen, S., Zhou, Y.-T., Wang, Z., Meidell, R. S., Unger, R. H., & Grayburn, P. A. (2000) · Circulation · doi:10.1161/01.cir.101.22.2554 · Cited by 446
Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Choyke, P. L., Dwyer, A. J., & Knopp, M. V. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10304 · Cited by 439
PARACEST Agents: Modulating MRI Contrast via Water Proton Exchange
Zhang, S., Merritt, M., Woessner, D. E., Lenkinski, R. E., & Sherry, A. D. (2003) · Accounts of Chemical Research · doi:10.1021/ar020228m · Cited by 436
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
Cai, W., Chen, K., Li, Z.-B., Gambhir, S. S., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043216 · Cited by 429
Self-citationZimmer, J. P., Kim, S.-W., Ohnishi, S., Tanaka, E., Frangioni, J. V., & Bawendi, M. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0579816 · Cited by 406
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 371
Catana, C., Wu, Y., Judenhofer, M. S., Qi, J., Pichler, B. J., & Cherry, S. R. (2006) · PubMed · Cited by 350
Chatziioannou, A. F., Cherry, S. R., Shao, Y., Silverman, R. W., Meadors, K., Farquhar, T. H., Pedarsani, M., & Phelps, M. E. (1999) · PubMed · Cited by 347
In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts
Chen, X., Conti, P. S., & Moats, R. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1956 · Cited by 347
Self-citationRadiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor Imaging
Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 340
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
A definition of molecular imaging.
Mankoff, D. A. (2007) · PubMed · Cited by 332
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Ciardiello, F., Caputo, R., Damiano, V., Caputo, R., Troiani, T., Vitagliano, D., Carlomagno, F., Veneziani, B. M., Fontanini, G., Bianco, A. R., et al. (2003) · PubMed · Cited by 328
Wu, Y., Zhang, X., Xiong, Z., Cheng, Z., Fisher, D. R., Liu, S., Gambhir, S. S., & Chen, X. S. (2005) · PubMed · Cited by 325
Self-citationImaging molecular interactions in living cells by FRET microscopy
Jares-Erijman, E. A., & Jovin, T. M. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.08.021 · Cited by 313
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
Nagengast, W. B., de Vries, E. G., Hospers, G. A., Mulder, N. H., de Jong, J. R., Hollema, H., Brouwers, A. H., van Dongen, G. A., Perk, L. R., & Lub-de Hooge, M. N. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041301 · Cited by 313
The role of VEGF in the regulation of physiological and pathological angiogenesis
Ferrara, N. (2005) · Mechanisms of Angiogenesis · doi:10.1007/3-7643-7311-3_15 · Cited by 312
Mansfield, J. R., Gossage, K. W., Hoyt, C. C., & Levenson, R. M. (2005) · Journal of Biomedical Optics · doi:10.1117/1.2032458 · Cited by 311 · cited 1×
“Because a significant background signal is usually observed for in vivo NIRF imaging as a result of tissue autofluorescence, spectral imaging techniques, in which the fluorescence signals of various fluorophores can be separated on the basis of their emission spectra (144,145), were used to better interpret the NIRF i…”
MethodDrevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Müller, M., Wood, J. M., Martiny‐Baron, G., Unger, C., & Marmé, D. (2000) · PubMed · Cited by 308
Willmann, J. K., Paulmurugan, R., Chen, K., Gheysens, O., Rodriguez-Porcel, M., Lutz, A. M., Chen, I. Y., Chen, X., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2462070536 · Cited by 301
Self-citationQuantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Self-citationPET of vascular endothelial growth factor receptor expression.
Cai, W., Chen, K., Mohamedali, K. A., Cao, Q., Gambhir, S. S., Rosenblum, M. G., & Chen, X. S. (2006) · PubMed · Cited by 262
Self-citationChen, X., Park, R., Tohme, M., Shahinian, A. H., Bading, J. R., & Conti, P. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0300403 · Cited by 260
Self-citationMulder, W. J. M., Strijkers, G. J., Habets, J. W., Bleeker, E. J. W., van der Schaft, D. W. J., Storm, G., Koning, G. A., Griffioen, A. W., & Nicolay, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-4145fje · Cited by 259
Smith, A. E. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.004111 · Cited by 258
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Chen, X. S., Hou, Y., Tohme, M. S., Park, R. J.-H., Khankaldyyan, V., Gonzales-Gomez, I., Bading, J. R., Laug, W. E., & Conti, P. S. (2004) · PubMed · Cited by 254
Self-citationLi, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
Self-citationMolecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles
Schmieder, A. H., Winter, P. M., Caruthers, S. D., Harris, T. D., Williams, T. A., Allen, J. S., Lacy, E. K., Zhang, H., Scott, M. J., Hu, G., et al. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20391 · Cited by 246
Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature
Korpanty, G., Carbon, J. G., Grayburn, P. A., Fleming, J. B., & Brekken, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1313 · Cited by 245
Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes
Backer, M. V., Levashova, Z., Patel, V., Jehning, B. T., Claffey, K., Blankenberg, F. G., & Backer, J. M. (2007) · Nature Medicine · doi:10.1038/nm1522 · Cited by 243
Engineering InAsxP1-x/InP/ZnSe III−V Alloyed Core/Shell Quantum Dots for the Near-Infrared
Kim, S.-W., Zimmer, J. P., Ohnishi, S., Tracy, J. B., Frangioni, J. V., & Bawendi, M. G. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0434331 · Cited by 242
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
Fonsatti, E., Altomonte, M., Nicotra, M. R., Natali, P. G., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206813 · Cited by 241
Cai, W., Chen, K., He, L., Cao, Q., Koong, A., & Chen, X. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0361-6 · Cited by 241
Self-citationA combined PET/CT scanner: the path to true image fusion
Townsend, D. W., & Beyer, T. (2002) · The British Journal of Radiology · doi:10.1259/bjr.75.suppl_9.750024 · Cited by 241
Licha, K., Riefke, B., Ntziachristos, V., Becker, A., Chance, B., & Semmler, W. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720392hcdaca2.0.co2 · Cited by 238
Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism
Cai, W., & Chen, X. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778226530 · Cited by 235
Self-citationNear-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3Expression in Living Mice
Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., & Chen, X. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501698 · Cited by 234
Self-citationYaghoubi, S. S., Barrio, J. R., Dahlbom, M. L., Iyer, M. R., Namavari, M., Satyamurthy, N., Goldman, R. B., Herschman, H. R., Phelps, M. E., & Gambhir, S. S. (2001) · PubMed · Cited by 230
Emerging concepts in molecular MRI
Sosnovik, D. E., & Weissleder, R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.11.001 · Cited by 227
18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis
Chen, X., Park, R., Shahinian, A. H., Tohme, M., Khankaldyyan, V., Bozorgzadeh, M. H., Bading, J. R., Moats, R., Laug, W. E., & Conti, P. S. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.10.002 · Cited by 212
Self-citationAngiogenesis inhibitors in clinical development; where are we now and where are we going?
Eskens, F. A. L. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601401 · Cited by 197
Molecular imaging with targeted contrast ultrasound
Kaufmann, B. A., & Lindner, J. R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.004 · Cited by 196
Wedge, S. R., Ogilvie, D., Dukes, M., Kendrew, J., Curwen, J., Hennequin, L. F., Thomas, A., Stokes, E. S. E., Curry, B. J., Richmond, G., et al. (2000) · PubMed · Cited by 192
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Self-citationAre quantum dots ready for in vivo imaging in human subjects?
Cai, W., Hsu, A. R., Li, Z.-B., & Chen, X. (2007) · Nanoscale Research Letters · doi:10.1007/s11671-007-9061-9 · Cited by 184
Self-citationVascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T. S., Tjarks, W., Barth, R. F., Claffey, K., & Backer, J. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0161 · Cited by 180
VEGF–integrin interplay controls tumor growth and vascularization
De, S., Razorenova, O., McCabe, N. P., O'Toole, T., Qin, J., & Byzova, T. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502935102 · Cited by 178
Integrin αβ3-Targeted Imaging of Lung Cancer
Chen, X., Sievers, E., Hou, Y., Park, R., Tohme, M., Bart, R., Bremner, R., Bading, J. R., & Conti, P. S. (2005) · Neoplasia · doi:10.1593/neo.04538 · Cited by 176
Self-citationHow molecular imaging is speeding up antiangiogenic drug development
Cai, W., Rao, J., Gambhir, S. S., & Chen, X. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0395 · Cited by 175
Self-citationCai, W., Zhang, X., Wu, Y., & Chen, X. S. (2006) · PubMed · Cited by 171
Self-citationMicro-PET Imaging of αvβ3-Integrin Expression with 18F-Labeled Dimeric RGD Peptide
Chen, X., Tohme, M., Park, R., Hou, Y., Bading, J. R., & Conti, P. S. (2004) · Molecular Imaging · doi:10.1162/1535350041464892 · Cited by 159
Self-citationMizuguchi, H., & Hayakawa, T. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1034 · Cited by 159
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide
Chen, X. S., Park, R. J.-H., Hou, Y., Khankaldyyan, V., Gonzales-Gomez, I., Tohme, M. S., Bading, J. R., Laug, W. E., & Conti, P. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1452-2 · Cited by 158
Self-citationSu, M., Cheung, Y., Fruehauf, J. P., Yu, H. J., Nalcioğlu, O., Mechetner, E. B., Kyshtoobayeva, A. S., Chen, S., Hsueh, S., McLaren, C. E., et al. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10380 · Cited by 155
Collingridge, D. R., Carroll, V. A., Glaser, M., Aboagye, E. O., Osman, S., Hutchinson, O. C., Barthel, H., Luthra, S. K., Brady, F., Bicknell, R., et al. (2002) · PubMed · Cited by 151
The role of ultrasound in molecular imaging
Liang, H.-D., & Blomley, M. J. K. (2003) · British Journal of Radiology · doi:10.1259/bjr/57063872 · Cited by 149
Liu, S., Hsieh, W., Jiang, Y., Kim, Y., Sreerama, S. G., Chen, X. S., Jia, B., & Wang, F. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603081 · Cited by 143
Self-citationHawighorst, H., Knapstein, P. G., Knopp, M. V., Weikel, W., Brix, G., ZUNA, I., Schönberg, S., Essig, M., Vaupel, P. W., & KAICK, G. V. (1998) · PubMed · Cited by 142
Simon, M., Röckl, W., Hornig, C., Gröne, E., Theis, H., Weich, H. A., Fuchs, E., Yayon, A., & Gröne, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961032 · Cited by 141
αvβ3-integrin imaging: a new approach to characterise angiogenesis?
Haubner, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0136-0 · Cited by 134
Targeted imaging using ultrasound contrast agents
Bloch, S. H., Dayton, P. A., & Ferrara, K. W. (2004) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2004.1360405 · Cited by 132
Transductional targeting of adenovirus vectors for gene therapy
Glasgow, J. N., Everts, M., & Curiel, D. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700928 · Cited by 131
Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles
Hu, G., Lijowski, M., Zhang, H., Partlow, K. C., Caruthers, S. D., Kiefer, G. E., Gulyas, G., Athey, P. S., Scott, M. J., Wickline, S. A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22581 · Cited by 127
UNDERINER, T. L., Ruggeri, B., & Gingrich, D. E. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455756 · Cited by 127
Wu, Z., Li, Z., Cai, W., He, L., Chin, F. T., Li, F., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0427-0 · Cited by 122
Self-citationCai, W., Olafsen, T., Zhang, X., Cao, Q., Gambhir, S. S., Williams, L. E., Wu, A. M., & Chen, X. S. (2007) · PubMed · Cited by 120
Self-citationA new PET tracer specific for vascular endothelial growth factor receptor 2
Wang, H., Cai, W., Chen, K., Li, Z., Kashefi, A., He, L., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0524-0 · Cited by 114
Self-citationBiochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor
Kumar, C. C., Nie, H., Rogers, C. P., Malkowski, M., Maxwell, E., Catino, J. J., & Armstrong, L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37071-5 · Cited by 111
Sun, J., Wang, D.-A., Jain, R. K., Carie, A., Paquette, S., Ennis, E., Blaskovich, M. A., Baldini, L., Coppola, D., Hamilton, A. D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208391 · Cited by 108
Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor.
Kumar, C. C., Huiming-Nie, C. P. R., Rogers, C. P., Malkowski, M., Maxwell, E., Catino, J. J., & Armstrong, L. (1997) · PubMed · Cited by 106
Current State of Imaging Protein-Protein Interactions In Vivo with Genetically Encoded Reporters
Villalobos, V. M., Naik, S. U., & Piwnica-Worms, D. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152044 · Cited by 105
Hsu, A. R., Cai, W., Veeravagu, A., Mohamedali, K. A., Chen, K., Kim, S., Vogel, H. S., Hou, L. C., Tse, V., Rosenblum, M. G., et al. (2007) · PubMed · Cited by 104
Self-citationNear-Infrared Fluorescence Imaging of Tumor Integrin αvβ3 Expression with Cy7-Labeled RGD Multimers
Wu, Y., Cai, W., & Chen, X. S. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0041-8 · Cited by 101
Self-citationMolecular and Functional Imaging of Cancer: Advances in MRI and MRS
Pathak, A. P., Gimi, B., Glunde, K., Ackerstaff, E., Artemov, D., & Bhujwalla, Z. M. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)86001-4 · Cited by 93
Instrumentation for Molecular Imaging in Preclinical Research: Micro-PET and Micro-SPECT
Chatziioannou, A. F. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200508-079ds · Cited by 93
Targeting vascular endothelium with avidin microbubbles
Korpanty, G. J., Grayburn, P. A., Shohet, R. V., & Brekken, R. A. (2005) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.06.001 · Cited by 88
Cai, W., & Chen, X. (2007) · Frontiers in bioscience · doi:10.2741/2386 · Cited by 87
Self-citationQuantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice
Cai, W., Ebrahimnejad, A., Chen, K., Cao, Q., Li, Z., Tice, D. A., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0503-5 · Cited by 86
Self-citationTropism-Modified Adenoviral and Adeno-Associated Viral Vectors for Gene Therapy
Nicklin, S. A., & Baker, A. H. (2002) · Current Gene Therapy · doi:10.2174/1566523023347797 · Cited by 78
In vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF
Blankenberg, F. G., Backer, M. V., Levashova, Z. B., et al. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0099-1 · Cited by 77
Assessment of angiogenesis: implications for ultrasound imaging
Forsberg, F., Ro, R. J., Potoczek, M., Liu, J., Merritt, C. R. B., James, K. M., Dicker, A. P., & Nazarian, L. N. (2003) · Ultrasonics · doi:10.1016/j.ultras.2003.12.026 · Cited by 66
Multimodality Tumor Imaging Targeting Integrin α v β 3
Cai, W., Gambhir, S. S., & Chen, X. S. (2005) · BioTechniques · doi:10.2144/000112091 · Cited by 65
Self-citationXiong, Z., Cheng, Z., Zhang, X., Patel, M., Wu, J. C., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 54
Self-citationHughes, M. S., Marsh, J. N., Zhang, H., Woodson, A. K., Allen, J. S., Lacy, E. K., Carradine, C., Lanza, G., & Wickline, S. A. (2006) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2006.1678189 · Cited by 50
The year(s) of the contrast agent – micro-MRI in the new millennium
Pautler, R. G., & Fraser, S. E. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00073-6 · Cited by 46
Cheung, A., Brown, A. S., Cucevic, V., Roy, M. M., Needles, A., Yang, V. X. D., Hicklin, D. J., Kerbel, R. S., & Foster, F. S. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.01.015 · Cited by 42
Watanabe, H., Mamelak, A. J., Wang, B., Howell, B. G., Freed, I., Esche, C., Nakayama, M., Nagasaki, G., Hicklin, D. J., Kerbel, R. S., et al. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00240.x · Cited by 42
Self-Assembled “Dock and Lock” System for Linking Payloads to Targeting Proteins
Backer, M. V., Patel, V., Jehning, B. T., & Backer, J. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060037u · Cited by 37
Spectral Imaging and Pathology: Seeing More
Levenson, R. M. (2004) · Laboratory Medicine · doi:10.1309/krnf-wqqe-uplq-l76l · Cited by 37
VEGF Expression in Osteosarcoma Correlates with Vascular Permeability by Dynamic MRI
Hoang, B. H., Dyke, J. P., Koutcher, J. A., Huvos, A. G., Mizobuchi, H., Mazza, B., Gorlick, R. G., & Healey, J. H. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000141492.52166.20 · Cited by 29
Molecular imaging can accelerate anti-angiogenic drug development and testing
Iagaru, A. H., Chen, X., & Gambhir, S. S. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0929 · Cited by 25
Self-citationNew imaging techniques in cancer management
Gwyther, S. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi727 · Cited by 18
Cited by
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Self-citationA Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Multimodality Imaging Probes: Design and Challenges
Louie, A. (2010) · Chemical Reviews · doi:10.1021/cr9003538 · Cited by 1,044
Metadata
- Authors
- Cai, W., & Chen, X.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2008-06
- Volume
- 49
- Issue
- Suppl 2
- Pages
- 113S-128S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2074707269
- Cited by
- 494
- References
- 142
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.